Background and aims: NK cell function is regulated by inhibitory and activating receptors including killer-
determined. Here, we identified a particular set of ligand and receptor genes that associated with better functionality of NK cells and better outcome upon exposure to HCV in a high risk group.
INTRODUCTION
People who inject drugs (PWID) are the most important risk-group for new infections with the hepatitis C virus (HCV) (1) . Sharing needles and other injection equipment is common practice and associated with high risk for HCV transmissions and incident infections resulting in prevalence rates of anti-HCV up to 80% in some PWID cohorts (1) . Although in Germany strategies for prevention of HCV transmission among PWID have been implemented in large cities, about 65% of PWID are still anti-HCV positive as a marker for past exposure to HCV (2) . Approximately 60-70% of the anti-HCV positive PWID are also positive for HCV-RNA as a marker for ongoing viral replication and are therefore at risk for onward transmission and progressive liver disease. In turn, the remaining 30-40% achieved immune control and spontaneously cleared viremia. Notably, epidemiological and immunological evidence suggest that repeated exposures to different HCV isolates are common in high-risk groups and individuals with multiple consecutive infections have been described (3) (4) (5) . Moreover, there is growing evidence that at least a subgroup of anti-HCV seronegative PWID was also exposed to HCV based on the reported risk behavior and the observation that T cell responses against HCV are detectable (6, 7). This subgroup is characterized by both distinct immunogenetics and immune cell function compared to healthy nonexposed individuals (8) (9) (10) , suggesting that early immune control prior to seroconversion is possible but not necessarily mediated by the same mechanisms that promote HCV clearance after seroconversion.
On a cellular level, CD8 + T cells play a crucial role in HCV clearance (11) . However, HCV-specific CD8 + T cells are only found in 25% to 58% of anti-HCV seronegative PWIDs (6, 7, 10) and become detectable only after weeks of infection (12) . In contrast, NK cells are activated very early upon exposure (13) and potentially contribute to both protection from persistent infection prior to seroconversion and resolution of acute Hepatitis C (reviewed in (14) ). Comparative analyses of individuals who spontaneously resolved HCV infection, individuals who develop chronic infection and HCV seronegative individuals with high-risk behavior provide an opportunity to understand the underlying mechanisms of protective immunity against HCV.
Numerous studies have highlighted substantial differences in adaptive immunity between patients with resolved HCV infection and patients with chronic infection (reviewed in(11)). Moreover, it has also been recognized that differences in innate immunity exist between both groups. A highly reproducible finding is the association between single nucleotide polymorphisms upstream of the IFNL3 gene locus and spontaneous resolution of HCV infection (15) (16) (17) . Genetic association studies also revealed that the genetically determined combinations of NK cell-receptors and its ligands are associated with differential outcome of HCV infection (18) . Specifically, PWID who are homozygous for the killer cell immunoglobulinlike receptor (KIR) KIR2DL3 and the receptor-ligand HLA-C1 are significantly enriched in the group of patients with spontaneous immune control of HCV (19) . This association was reproduced in different cohorts and was extended to anti-HCV seronegative high-risk PWID (8, (20) (21) (22) . However, other genetic association studies did not confirm the same finding (23, 24) or revealed different associations between genetic KIR/KIR-ligand combinations and control of HCV (23, 25) . Thus genetic determinants of immune control of HCV might differ between cohorts.
Here, the influence of the genetically determined combinations of KIR and KIR-ligands on the outcome of 
PATIENTS AND METHODS

Study subjects
Blood samples from patients with a history of injection drug use were collected from the ward for KIR and HLA genotyping DNA of patients was extracted from PBMCs using spin columns (Qiagen, Hilden, Germany). The KIR genotyping was performed as previously described (10) . HLA class I typing was performed by use of sequence-specific oligonucleotides (LABType methodology) both provided by One Lambda Inc. (Canoga Park, CA). DNA-based KIR3DL1 allele subtyping and subgroup determination (null, low, high) was performed as previously described with adjusted cycling conditions (26) .
Analysis of NK cells
PBMCs were stimulated in RPMI 1640 medium containing 10% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES buffer, and 10 ng/ml Brefeldin A (Sigma Aldrich) with K562 at an effector-target ratio of 10:1 for 5 h. Subsequently NK cells were analyzed via flow cytometry. All antibodies used are indicated in the Supplementary CTAT Table (Table S3. ). K562 cells were tested negative for mycoplasma.
Statistical analysis
Associations between KIR/KIR-ligands and infection were determined using univariate and multivariate analyses to determine factor selection and test independence. Multivariate logistic regression was applied using the backward stepwise procedure for all variables that were significant at univariate analysis. Relationships were estimated using the odds ratio (OR) and its 95% Confidence Intervals.
Routine statistical software packages were used for the analyses (SPSS version 21, GraphPad Prism 6.0 software). A p<0.05 was considered to be statistically significant. Statistical analyses of NK cell frequencies and function were performed using GraphPad Prism 5.04 software (GraphPad Software, San Diego California USA). Data were examined for normal distribution and followed by an equivalent outlier test. For the comparison of two groups either a parametric or nonparametric t-test was performed.
Three or more groups were compared by one-way analysis of variance (ANOVA) or a Kruskal-Wallis test. confirming the protective effect that was observed in the PWID cohort from Germany (Fig. 1 ). An overview of the HLA allele frequencies in both cohorts is given in Table S2 .
RESULTS
It has been reported that the copy number of KIR-ligands can also influence the functionality of NK cells (27) (28) (29) . We therefore addressed if the HLA-Bw4 copy number was associated with the HCV infection (data not shown) were observed when the different PWID groups were compared. Moreover, there were also no functional differences between KIR3DL1 + NK cells regarding secretion of IFNγ (Fig. 2B) , TNFα or CD107a expression (data not shown) between the different groups.
As the KIR3DL1 gene locus is highly polymorphic and different alleles have been linked to different KIR3DL1 expression levels, a previously described multiplex PCR assay(26) was used to characterize the KIR3DL1 gene of 60 PWID included in the flow cytometric analysis in more detail. Based on the PCR results three groups were defined. PWID that were homozygous for non-expressing KIR3DL1 genes were grouped (KIR3DL1 null). PWID that were either homozygous for low expressing KIR3DL1 genes or encoded a KIR3DL1 low expressing gene in combination with either a non-expressing KIR3DL1 gene or a KIR3DS1 gene were grouped (KIR3DL1 low). PWID who were homozygous for high expressing KIR3DL1 genes or encoding one high expressing KIR3DL1 gene in combination with either a low or non-expressing KIR3DL1 gene or a KIR3DS1 gene were grouped (KIR3DL1 high). As previously described(30) the KIR3DL1 subgenotype closely correlated with the frequency of KIR3DL1 + NK cells (Fig. 2C ) and KIR3DL1 expression level (data not shown). However, there was no difference between PWID with different HCV infection status.
HLA-Bw4 copy number correlates with NK cell functionality in healthy individuals but not in PWID
As the genetic analysis revealed that PWID with two or more HLA-Bw4 motifs were enriched in the HCV-RNA negative group and in the anti-HCV seronegative group, we next grouped PWID according to Bw4 copy number rather than HCV infection status and analyzed IFNγ, TNFα and CD107a expression in response to stimulation with K562 cells. Although there was a trend towards better functionality of NK cells from donors carrying multiple HLA-Bw4 motifs, we did not see significant differences between the groups (Fig. 3 A-C) . To validate the finding, we stimulated PBMCs isolated from 120 healthy donors using the same stimulation and staining protocol that was used to analyze the PWID cohort. In the healthy cohort a significant stepwise increase of IFNγ (Fig. 3D) and CD107a (Fig.3F ) production was observed in individuals with no, one or at least two Bw4 motifs. In addition, healthy individuals with two or more Bw4 motifs produced significantly more TNFα than individuals with no or one Bw4 motif. These findings are in line with a previous study performed in healthy individuals (29) .
HLA-Bw4 80(T) associates with better NK cell functionality in PWID but not in healthy controls (Fig. 4D-F) .
DISCUSSION
In this study the influence of the genetically determined KIR/KIR-ligand combination on the outcome of HCV infection was analyzed in a high-risk cohort of HCV-treatment naïve PWID. The cohort was grouped into anti-HCV seropositive PWID with detectable HCV-RNA, anti-HCV seropositive PWID without detectable HCV-RNA and anti-HCV seronegative PWID. Although longitudinal data are not available, the anti-HCV seropositive group without detectable HCV-RNA putatively consists predominantly of PWID who spontaneously resolved HCV infection whereas the HCV-RNA positive group predominantly represents PWID with chronic HCV infection. Importantly, based on the experience from previous studies, exposure to HCV may also be common in the group of anti-HCV seronegative PWID with highrisk behavior (6, 7) . Although exposure to HCV is difficult to prove in the absence of serological markers for infection, there is growing evidence that the anti-HCV seronegative group is immunologically distinct and may therefore be able to achieve control of viral replication prior to detectable humoral immune responses(8-10).
Here, the genetic association study suggested two distinct genetic predispositions resulting in either preferential spontaneous resolution of hepatitis C or in a protective state against HCV infection prior to seroconversion. KIR3DL1 combined with a high copy number of HLA-Bw4 alleles -defined here as two alleles or more -was associated with an anti-HCV seronegative state. This is consistent with a functional CC-or CT-genotype, no corresponding difference was found in healthy individuals (36) . Taken together with our findings, this may indicate that HCV exposure itself perturbs the NK cell compartment in a more complex way than previously appreciated.
Previous studies revealed an association between KIR2DL3 combined with homozygosity for its ligand HLA-C1 and spontaneous clearance of hepatitis C as well as a protective state in anti-HCV seronegative PWID (8, (19) (20) (21) (22) ; however, partially conflicting results were observed in different cohorts and distinct "protective" KIR/KIR-ligand associations have been reported in some studies (23, 24) . Of note, while on the genetic level we do not see a beneficial effect for KIR2DL3 and HLA-C1 in our German PWID cohort, we have previously reported that, on a phenotypic level, higher expression of KIR2DL3 is associated with spontaneous immune control of HCV and protection from infection (10) . Collectively, the existing data from genetic association studies support the idea that the genetic correlates for "protection" against HCV infection are not universal and that the pathways to immune control involve multiple discrete factors (37) . This also includes the genetic determinants of the CD8 + T cell response, that plays an important role in antiviral immunity against hepatitis C. In particular, presence of HLA-B*27 and HLA-B*57 was reproducibly associated with spontaneous immune control of HCV infection (38) (39) (40) (41) . Notably, in our cohort of PWID HLA-B*27:05 was also associated with a protective effect against HCV (data not Although KIR3DL1 has not been previously described to influence the natural course of HCV infection, the combination of KIR3DL1 and HLA-Bw4 alleles has recently been described to influence treatment outcome. In a Japanese cohort of patients infected with genotype 1 the IL28B genotype and the KIR3DL1/HLA-Bw4 genotype were independent predictors for treatment success upon combination therapy with pegIFNα and ribavirin (43) . The combination of KIR3DL1 and HLA-Bw4 has been associated with beneficial effects in other diseases. For example, protection from diffuse large B-cell lymphoma was described in a cohort of Thai patients (44) 
